This study aimed to analyse whether the functional quality of spermatozoa is associated with body mass index (BMI). Semen samples were obtained from 1824 men undergoing fertility evaluation/treatment. Semen analysis was performed using World Health Organization (WHO) criteria, and morphology was evaluated with the motile sperm organelle morphology examination (MSOME). The percentages of sperm DNA fragmentation (using TdT (terminal deoxynucleotidyl transferase)-mediated dUTP nick-end labelling (TUNEL) assays), sperm chromatin packaging/underprotamination (using chromomycin A3/CMA 3 ), mitochondrial damage (using MitoTracker Green) and apoptosis (using annexin V) were also assessed. At least 200 spermatozoa were examined in each evaluation. The following BMI values were used as cut-off points: ≤24.9 kg/m 2 , 25-29.9 kg/m 2 (overweight) and ≥30 kg/m 2 (obese). High BMI negatively affects sperm concentration, vitality, motility and morphology (p < .05).
Concerning men, a decline in semen quality was reported in parallel to the obesity epidemic. Nevertheless, the studies addressing specific relationships between semen parameters and obesity have yielded contradictory results. Although some recent data suggest a correlation between the increase in obesity and a reduction in sperm concentration, motility and/or morphology (Alshahrani, Ahmed, Gabr, Abalhassan, & Ahmad, 2016; Belloc et al., 2014; Bieniek et al., 2016; Dupont et al., 2013; Eisenberg et al., 2014; Luque et al., 2015;  MacDonald, Stewart, & Farquhar, 2013; Taha et al., 2016; Umul et al., 2015) , other studies did not detect statistically significant adverse effects of obesity on semen quality (Bandel et al., 2015; Thomsen, Humaidan, Bungum, & Bungum, 2014) . Although three metaanalyses were published, the contradictions remain. MacDonald, Herbison, Showell, and Farquhar (2010) did not find evidence of an association between increased obesity and semen parameters. The main limitation of this review is that data from most studies could not be aggregated for meta-analysis. Later, Sermondade et al. (2013) observed that overweight and obesity were associated with an increased prevalence of azoospermia or oligozoospermia. The main limitation of this report is that the studied populations varied, with men recruited from both the general population and infertile couples. Subsequently, in the meta-analysis of Campbell, Lane, Owens, and Bakos (2015) , a clinically significant association was not found for conventional semen (except abnormal morphology), despite the demonstration that paternal obesity negatively affects male fertility.
However, many studies could not be aggregated, and some analyses found significant heterogeneity between studies. Nonconventional parameters of semen quality were also assessed and were mainly related to DNA damage; however, the number of such studies is still small, or their results are contradictory.
Given the discrepancies among study results and the belief that an understanding of the relationship between obesity and male fertility will allow better counselling of infertile couples, this study aimed to analyse whether sperm quality (volume, pH, concentration, motility, morphology and vitality) or sperm DNA integrity (DNA fragmentation, apoptosis, underprotamination and mitochondrial damage) are associated with obesity assessed based on the body mass index (BMI).
| MATERIALS AND METHODS

| Population
Semen samples (one per subject) were obtained from 1824 men from a random group of couples undergoing infertility investigation and treatment from January 2011 to December 2015 at the Centre for Human Reproduction Prof. Franco Jr. No men received an antioxidant treatment beforehand. Exclusion criteria were azoospermia, any known reproductive tract pathology in the last six months, any hormonal therapy in the last six months, chronic medical disorders, congenital genital tract abnormalities or previous treatment that can alter fertility (cancer treatment). Written informed consent was obtained from all participants, and this study was approved by the institutional review board and its local ethics committees. 
| BMI determination
| Sample collection
Semen samples were collected in sterile containers by masturbation after a sexual abstinence period of 2-5 days. A portion of each semen sample was used for analysis according to the WHO guidelines (WHO, 2010) . The other portion of each semen sample was immediately processed for morphological analysis by motile sperm organelle morphology examination (MSOME). The remainder of the semen samples was immediately processed for sperm DNA fragmentation analysis using the TdT (terminal deoxynucleotidyl transferase)-mediated dUTP nick-end labelling (TUNEL) assay, sperm apoptosis analysis using the annexin V assay, sperm chromatin packing/protamination using chromomycin A3 (CMA 3 ) staining and sperm mitochondrial membrane potential (MMP) using MitoTracker Green FM.
| Determination of morphology by MSOME
MSOME procedures were performed as described previously (Oliveira et al., 2014; Silva et al., 2012) . At least 200 motile spermatozoa per sample were evaluated, and the percentages of normal spermatozoa were determined.
| Determination of sperm DNA fragmentation
DNA fragmentation in spermatozoa was measured using the TUNEL assay, which was performed using an in situ cell death detection kit with tetramethylrhodamine red-labelled dUTP (Roche), as described previously (Oliveira et al., 2014; Vagnini et al., 2007) . The final evaluation was performed using a fluorescence microscope (Olympus BX 50), and the percentage of TUNEL-positive spermatozoa was determined. At least 200 spermatozoa were evaluated for each slide, with the appropriate filter.
| Determination of sperm chromatin packaging/ protamination
Sperm protamine deficiency (underprotamination)/chromatin packaging was measured using CMA 3 (Sigma-Aldrich), as described previously . The percentage of positive spermatozoa was determined by direct observation in four fields using a fluorescence microscope (Olympus BX 50), and the percentages of spermatozoa with abnormal chromatin packaging were determined. At least 200 spermatozoa were evaluated for each slide, with the appropriate filter.
| Determination of sperm apoptosis
Sperm apoptosis was measured using annexin V, a calcium-dependent phospholipid-binding protein with a high affinity for phosphatidylserine that is present in the inner leaflet of the sperm membrane, except in apoptotic spermatozoa, where phosphatidylserine is externalised. 
| Quality control
To control for intra-observer and inter-observer variability, multiple fractions of semen samples were obtained from randomly selected patients. Each sample was observed at least three times by the same observer (blinded to subject identity). Intra-observer and Inter-observer variations of ≈0.5-1% and 0.5-7%, respectively, were obtained for 
| Sample size
Sample size was calculated by performing a comparison between two proportions. A sample size of 250 subjects in each group has 80% power to detect an increase of 15% with a significance level of 0.05 (two-tailed).
| Statistical analysis
The data were analysed using the StatsDirect statistical software Mann-Whitney U-test, Student t-test and chi-squared test were used, as appropriate.
The level of significance was set at p < .05.
| RESULTS
| General population characteristics
The regression analysis did not show a correlation between BMI and subject age, history of fathering at least one child (or generating a pregnancy that had ended in miscarriage), time of infertility, tobacco use, regular alcohol use, presence of varicocele and vitamin supplement use. Confirming the results observed with regression analysis, an equal distribution (p > .05) of the main characteristics was observed for all three BMI groups. Table 1 summarises the data.
In addition, a multiple regression analysis was performed to control for the these factors together and again no correlation with BMI was observed.
| Semen quality and general semen parameters (Table 2)
Regression 37.9 ± 6.6
38.3 ± 7.0 37.8 ± 6.5
38.0 ± 6.4
. Because spermatogenesis requires a controlled testicular environment and intact endocrine signalling via the hypothalamic-pituitary-testicular axis, the impact of obesity on semen quality might be mainly attributed to endocrine mechanisms. In obese men, insulin causes a reduction in sex hormone-binding globulin (SHBG) levels, with a consequent increase in the androgens available for conversion to oestrogen by adipose tissue aromatase (Hajshafiha, Ghareaghaji, Salemi, Sadegh-Asadi, & Sadeghi-Bazargani, 2013; Håkonsen et al., 2011; MacDonald et al., 2010; Palmer, Bakos, Fullston, & Lane, 2012; Teerds, de Rooij, & Keijer, 2011) . In addition, in all obese men, the serum levels of total and bioavailable testosterone and inhibin B are reduced, which is associated with a decrease in the luteinising hormone (LH) pulse amplitude (Crujeiras & Casanueva, 2015; Hajshafiha et al., 2013; Håkonsen et al., 2011; MacDonald et al., 2010; Palmer et al., 2012; Stewart et al., 2009; Tunc, Bakos, & Tremellen, 2011; Vermeulen, Kaufman, Deslypere, & Thomas, 1993) . This hormonal profile suggests an increase in the oestrogen-induced pituitary negative feedback and a reduction in testosterone secretion by Leydig cells (Crujeiras & Casanueva, 2015; Hajshafiha et al., 2013; Hofny et al., 2010; Leisegang et al., 2014; Palmer et al., 2012; Tunc et al., 2011; Vermeulen et al., 1993) . In addition, a preferential accumulation in the adipose tissue of toxic substances and fat-soluble endocrine disruptors might amplify these abnormalities (Katib, 2015; Sermondade et al., 2013) . Furthermore, obese men are predisposed to an increase in scrotal temperature, due to the accumulation of fatty tissue around the scrotum, which may cause oxidative stress in the testicles with consequent adverse effects on semen parameters (Crujeiras & Casanueva, 2015; Fariello et al., 2012; Jung & Schill, 2000; Palmer et al., 2012 Values within rows with the same superscripted letter are significantly different.
to confirm our findings (Belloc et al., 2014) . A negative correlation between vitality and BMI, which is more frequently assessed, was also reported by Leisegang et al. (2014) , Andersen et al. (2015) and Taha BMI and sperm concentration (Campbell et al., 2015; MacDonald et al., 2010) . However, the results reported in the literature exhibit wide variation. In contrast to the just-reported findings, in our study, the sperm concentration exhibited a significant negative correlation with BMI, which is not an isolated finding. The results of other studies, including some recent ones, agree with ours (Alshahrani et al., 2016; Bakos, Henshaw, Mitchell, & Lane, 2011; Belloc et al., 2014; Bieniek et al., 2016; Braga et al., 2012; Eisenberg et al., 2014; Fariello et al., 2012; Hammiche et al., 2012; Hammoud et al., 2008; Hofny et al., 2010; Jensen et al., 2004; Luque et al., 2015; Sermondade, Faure, et al., 2012; Stewart et al., 2009; Taha et al., 2016; Tunc et al., 2011) .
In addition, in their meta-analysis, Sermondade et al. (2013) found that overweight and obesity were associated with an increased prevalence of azoospermia or oligozoospermia.
In our study, both the total and progressive sperm motility exhib- Rybar et al., 2011; Shayeb et al., 2011) . In addition, Bandel et al. (2015) found that obese men had a higher percentage of progressive motile spermatozoa than did normal-weight men. The available metaanalyses reflect such contradictory results. Although MacDonald et al.
(2010) did not detect a significant correlation between sperm motility and BMI in their meta-analysis, Campbell et al. (2015) showed a small but significant decrease in motility for obese men in the overall population (general population and infertile couples), with a nonsignificant trend of a decrease in the infertile population.
Our MSOME results for evaluating morphology showed a significant decrease in the percentage of morphologically normal spermatozoa as BMI increased. Unfortunately, few studies used MSOME as a criterion for morphological analysis, which makes the interpretation of the observed correlation challenging. Some studies applied different morphological criteria (e.g., morphology by the WHO criteria or
Kruger's strict criteria), and the results agree with ours and also indicate a correlation between an increase in obesity and poorer sperm morphology (Bieniek et al., 2016; Hofny et al., 2010; La Vignera et al., 2012; Luque et al., 2015; MacDonald et al., 2013; Shayeb et al., 2011; Taha et al., 2016) . However, different authors failed to find any relationship (Alshahrani et al., 2016; Bakos et al., 2011; Belloc et al., 2014; Chavarro et al., 2010; Duits et al., 2010; Dupont et al., 2013; Eisenberg et al., 2014; Fariello et al., 2012; Hajshafiha et al., 2013; Leisegang et al., 2014; Martini et al., 2010; Pauli et al., 2008; Qin et al., 2007; Umul et al., 2015) . The available meta-analyses make these divergences even more evident. MacDonald et al. (2010) observed that the largest study included found no significant association between BMI and sperm morphology, although the results from smaller studies varied. On the contrary, Campbell et al. (2015) found that in their meta-analysis of studies using the WHO criteria, when the analysis was restricted to the clinical assisted reproduction technology (ART) population, the poorer morphology for obese men compared with normal-weight men was statistically significant. However, when the analysis also included studies that were conducted with the overall population, a nonsignificant decrease was found. When studies using
Kruger's criteria were subjected to meta-analysis, the results showed no significant differences.
Several issues should be considered when evaluating the discrepancies among studies on the BMI-semen quality relationship. The sample size might possibly explain the variation among studies because an analysis of larger populations might yield more consistent data. Nevertheless, studies with samples composed of more than 1,000 individuals reported variable results. Similarly to us, some authors found significant abnormalities in the analysed set of semen parameters as BMI increased (motility, concentration and morphology) (Bieniek et al., 2016; Tsao et al., 2015) ; however, several others reported a selective decline in some semen parameters (Belloc et al., 2014; Jensen et al., 2004; Paasch, Grunewald, Kratzsch, & Glander, 2010; Shayeb et al., 2011) or did not find any significant relationship between semen parameters and BMI (Aggerholm et al., 2008; Bandel et al., 2015; Duits et al., 2010) . In essence, these results reproduce the distribution of the results obtained from the analysis of smaller populations. The reproductive status of a population (fertile/overall population or subfertile) might also influence the results. However, once again, studies either demonstrate or refute the correlation between an increase in BMI and poorer semen quality, even when using selective approaches (some parameters only) in studies targeting the subfertile population (Alshahrani et al., 2016; Belloc et al., 2014; Bieniek et al., 2016; Eisenberg et al., 2014; Luque et al., 2015; Tang et al., 2015) and in studies of the overall population (Aggerholm et al., 2008; Andersen et al., 2015; Bandel et al., 2015; Jensen et al., 2004; Kort et al., 2006; Taha et al., 2016; Tsao et al., 2015) . This issue is complicated by the actual degree of reliability of the classification of the population reproductive status because subfertile individuals are usually identified as members of couples under assessment/treatment for infertility.
Differences in the methods used to assess the sperm quality among laboratories and in statistical analysis methods likely contribute to the differences between these studies. The study of sperm morphology provides an illustrative example of the high inter-rater variability and the differences in the standards used for categorisation.
One should still consider confounding factors, which might further affect the sperm quality. Similar to our study, most studies also control for factors such as age, abstinence, use of recreational drugs and infection in the analysis of the relationship between semen parameters and BMI. However, additional observations of other unusual factors could provide more important information about controversial results.
Differences in the genetic backgrounds of various ethnic populations
should also be considered. In addition, the possibility of harder to control/assess factors, such as diet type and action of pollutants, should also be taken into account.
Male obesity has been associated with a reduction in pregnancy and live birth rates Campbell et al., 2015) , and one plausible explanation for these results is that obese men may have more spermatozoa with damaged DNA. Defects in protamination and apoptosis were suggested as an explanation for sperm DNA fragmentation (Agarwal, Virk, Ong, & du Plessis, 2014; Sakkas & Alvarez, 2010) . Our study, which used a CMA 3 (which binds to the same DNA sites as protamines) assay, failed to detect any relationship between protamination level/chromatin packing and BMI. Using this same technique (the CMA 3 assay), Rybar et al. (2011) also did not detect an effect of BMI on protamination. Similarly, using annexin V, we did not find any relationship between apoptosis and BMI. In contrast, La Vignera et al. (2012) found a statistically significant higher percentage of early apoptotic spermatozoa in overweight and obese men than in normal-weight men; this parameter was assessed also using annexin V.
However, only a small number of patients (50 control, 50 overweight and 50 obese) were included. The paucity of published studies hinders the comparison of results; nonetheless, obesity seems to have little or no influence on both apoptosis and sperm protamination. Additional studies on this topic are welcome.
The TUNEL assay using fluorescence microscopy in our study was performed using a large population, and an increased risk of sperm DNA fragmentation was not observed in obese or overweight men.
Some other published studies have reported conflicting results, possibly because of the heterogeneity of the techniques (some measured denatured DNA rather than proper DNA fragmentation) and the small samples used in some studies. Different from our results, Kort et al. (2006) , who used the sperm chromatin structure assay (SCSA),
and Taha et al. (2016) , who used flow cytometry based on the fluorescence emission from individual spermatozoon stained with PI, reported an increased sperm DNA fragmentation rate in overweight and obese patients. Leisegang et al. (2014) , who used the TUNEL assay with fluorescence microscopy, observed that obesity was associated with increased sperm DNA fragmentation. Chavarro et al. (2010) and Fariello et al. (2012) , who used the comet assay method, La Vignera et al. (2012) , who used the TUNEL assay with flow cytometry, and Dupont et al. (2013) , who used the TUNEL assay with fluorescence microscopy, observed higher sperm DNA damage in obese men but not in overweight men. However, these studies were conducted using a relatively small population (ranging from 150 to 520), and some of these studies do not adjust for confounders such as age and tobacco.
A recent meta-analysis (Campbell et al., 2015) reported a statistically significant increase in the percentage of spermatozoa with DNA fragmentation in obese men compared with normal-weight men, but only four studies with a small population could be included.
Nevertheless, many studies agree with ours. For infertile populations, Tunc et al. (2011) , who used the TUNEL assay with fluorescence microscopy, and Smit, Romijn, Wildhagen, Weber, and Dohle (2010), Hammiche et al. (2012) , Rybar et al. (2011) and Thomsen et al. (2014) , who used the SCSA method, did not find any significant association between BMI and sperm DNA integrity, but only small populations (ranging from 81 to 612) were used for these studies. With general populations and the SCSA method, Håkonsen et al. (2011 Håkonsen et al. ( , 2012 , Eisenberg et al. (2014) and Andersen et al. (2015) also reported increased sperm DNA fragmentation in overweight and obese patients, but these populations were also small (ranging from 43 to 501).
However, Bandel et al. (2015) used the SCSA method in a study that was based on semen samples from 1503 men from a general population and found that high BMI is not associated with increased sperm DNA fragmentation. With these controversial results, further evaluation of the relation between obesity and DNA fragmentation is needed, but DNA fragmentation may not be the answer to the reduction in clinical finding following infertility treatment in obese/overweight men.
Although reactive oxygen species (ROS) participate in essential activities, such as the acrosome reaction, an imbalance between the semen antioxidative capacity and ROS production results in oxidative stress, which is a major cause of sperm function damage (Agarwal et al., 2014; Aitken, Jones, & Robertson, 2012; Fariello et al., 2012; Treulen, Uribe, Boguen, & Villegas, 2015) . Increased ROS production has been associated with alterations in the mitochondrial membrane permeability, possibly leading to loss in the MMP and eventually to DNA fragmentation and the death of both somatic cells and spermatozoa (Agarwal et al., 2014; Aitken et al., 2012; Kroemer, Galluzzi, & Brenner, 2007; Malić Vončina et al., 2016; Treulen et al., 2015) . We assessed MMP by JC-1 staining, Fariello et al. (2012) , who used the deposition of diaminobenzidine (DAB), and Leisegang et al. (2014) , who used a DePsipher staining kit, demonstrated that the percentage of spermatozoa that had altered MMP was significantly higher in obese men than in normal-weight men. In addition, obese men presented with a higher percentage of spermatozoa with low MMP than overweight men (La Vignera et al., 2012) . In contrast to our results, all these studies reported a concomitant increase in sperm DNA fragmentation in parallel as obesity increased. Differences in sample size (42-305 vs. 1,824 men) or in the techniques employed might account for this discrepancy. However, such interconnection (MMP loss/alteration) might not be the only factor affecting sperm DNA fragmentation (Lobascio et al., 2015; Malić Vončina et al., 2016) .
Abnormalities in mitochondrial function might affect the sperm motility due to possible oxidative phosphorylation inhibition; for the latter, this change will result in decreased ATP production and thus a reduction in the availability of energy. Supporting this possible correlation, in our study, MMP was negatively correlated with vitality (r = −.026, p < .0001) and motility (total: r = −.31, p < .0001; progressive: r = −.29, p < .0001). Leisegang et al. (2014) report the same finding.
The major strength of this study is the large sample size. In addition, the study population comprised men from different age groups and included a large number of overweight and obese men, and the analysis controlled for intra-and inter-technician variability. The limitations were that BMI was the only studied measure of obesity and that the data were cross-sectional. The number of patients presenting overweight or obesity is very important (79.7%). Furthermore, because this study was conducted using couples who sought fertility treatment, it could be biased towards infertility. Caution should be used if generalising these results to the general population.
In conclusion, increased BMI in infertile men may negatively affect sperm quality. BMI does not seem to be associated with sperm DNA fragmentation, sperm apoptosis or sperm protamination but is associated with increased mitochondrial damage. Given the adverse consequences of obesity and the possible negative role of male BMI, the benefits of weight reduction should be discussed when counselling couples interested in fertility treatment. Analogous to some clinical conditions such as cardiovascular diseases or diabetes, it is believed that weight loss can benefit male fertility, helping to restore normality of hormonal profiles (ASRM, 2015; El Bardisi et al., 2016) .
However, existing data on the benefits of weight loss are unclear, and it should be noted the lack of well-designed studies that demonstrate improvement in seminal quality with BMI reduction (ASRM, 2015; El Bardisi et al., 2016) . On the other hand, abrupt weight loss with restriction of intake/absorption of important nutrients can lead to worsening seminal quality (El Bardisi et al., 2016; Sermondade, Massin, et al., 2012) .
